CO4840509A1 - 2,4 diaminopirimidinas sustituidas, medicamento que contiene dichos compuestos para el control o la prevencion de enfermedades infecciosas y procedimiento para la preparacion de dichos compuestos" - Google Patents
2,4 diaminopirimidinas sustituidas, medicamento que contiene dichos compuestos para el control o la prevencion de enfermedades infecciosas y procedimiento para la preparacion de dichos compuestos"Info
- Publication number
- CO4840509A1 CO4840509A1 CO97025823A CO97025823A CO4840509A1 CO 4840509 A1 CO4840509 A1 CO 4840509A1 CO 97025823 A CO97025823 A CO 97025823A CO 97025823 A CO97025823 A CO 97025823A CO 4840509 A1 CO4840509 A1 CO 4840509A1
- Authority
- CO
- Colombia
- Prior art keywords
- compounds
- prevention
- procedure
- preparation
- control
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000035473 Communicable disease Diseases 0.000 title 1
- 229940058936 antimalarials diaminopyrimidines Drugs 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 abstract 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004475 heteroaralkyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuestos de la fórmula general I: en donde R1 significa alcoxilo inferior, R2 significa bromo alcoxilo inferior o hidroxilo, R3 significa hidrógeno, alquilo inferior, cicloalquilo, arilo, heteroarilo, aralquilo, heteroaralquilo o ciano, R4 y R5 significan cada uno, independientemente, hidrógeno, alquilo inferior, alcoxilo inferior, halógeno, hidroxilo, amino, di(alquilo inferior)- amino, ciano o nitro y Q significa etinileno o vinileno, así como sus sales farmacéuticamente utilizables.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96107739 | 1996-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4840509A1 true CO4840509A1 (es) | 1999-09-27 |
Family
ID=8222784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO97025823A CO4840509A1 (es) | 1996-05-15 | 1997-05-14 | 2,4 diaminopirimidinas sustituidas, medicamento que contiene dichos compuestos para el control o la prevencion de enfermedades infecciosas y procedimiento para la preparacion de dichos compuestos" |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5866583A (es) |
| EP (1) | EP0901488B1 (es) |
| JP (1) | JP3098259B2 (es) |
| KR (1) | KR100295509B1 (es) |
| CN (1) | CN1098260C (es) |
| AR (1) | AR007088A1 (es) |
| AT (1) | ATE227282T1 (es) |
| AU (1) | AU726416B2 (es) |
| BR (1) | BR9709251A (es) |
| CA (1) | CA2254117C (es) |
| CO (1) | CO4840509A1 (es) |
| CY (1) | CY2425B1 (es) |
| CZ (1) | CZ364698A3 (es) |
| DE (1) | DE69716901T2 (es) |
| DK (1) | DK0901488T3 (es) |
| ES (1) | ES2184089T3 (es) |
| HR (1) | HRP970260A2 (es) |
| IL (1) | IL126702A0 (es) |
| MA (1) | MA24182A1 (es) |
| NO (1) | NO985335L (es) |
| NZ (1) | NZ332481A (es) |
| PE (1) | PE78898A1 (es) |
| PL (1) | PL330277A1 (es) |
| PT (1) | PT901488E (es) |
| TR (1) | TR199802331T2 (es) |
| TW (1) | TW438796B (es) |
| WO (1) | WO1997043277A1 (es) |
| YU (1) | YU51498A (es) |
| ZA (1) | ZA973984B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998039328A1 (en) * | 1997-03-03 | 1998-09-11 | F.Hoffmann-La Roche Ag | Substituted 2,4-diaminopyrimidines |
| PT966464E (pt) * | 1997-03-03 | 2003-09-30 | Basilea Pharmaceutica Ag | 2,4-diaminopirimidinas substituidas |
| US6277860B1 (en) * | 1999-10-29 | 2001-08-21 | Pfizer Inc | Furopyridine antibacterials |
| US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
| US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
| CA2528834A1 (en) * | 2003-06-13 | 2005-02-10 | Arena Pharmaceuticals, Inc. | 5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases |
| CA2534221A1 (en) * | 2003-08-07 | 2005-02-24 | Merck & Co., Inc. | Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| WO2005016278A2 (en) | 2003-08-12 | 2005-02-24 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
| DE102005062987A1 (de) * | 2005-12-28 | 2007-07-05 | Grünenthal GmbH | Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln |
| CN101784515A (zh) * | 2007-08-03 | 2010-07-21 | 弗·哈夫曼-拉罗切有限公司 | 作为taar1配体的吡啶甲酰胺和苯甲酰胺衍生物 |
| BRPI0921097B8 (pt) * | 2008-11-21 | 2021-05-25 | Raqualia Pharma Inc | composto ou seu sal farmaceuticamente aceitável, intermediário do composto, composição farmacêutica e uso do composto |
| EP2389376A1 (en) * | 2009-01-21 | 2011-11-30 | Basilea Pharmaceutica AG | Novel bicyclic antibiotics |
| WO2011073101A1 (de) * | 2009-12-15 | 2011-06-23 | Bayer Cropscience Ag | Verfahren zur herstellung von 1-alkyl-/1-aryl-5-pyrazolcarbonsäurederivaten |
| MA35024B1 (fr) | 2011-04-05 | 2014-04-03 | Pfizer Ltd | Dérivés de pyrrolo-[2,3-d]pyrimidine servant d'inhibiteurs des kinases apparentés à la tropomyosine |
| DE102013208484B4 (de) | 2013-05-08 | 2018-04-26 | Wirtgen Gmbh | Vorrichtung zum Bearbeiten von Straßen- oder Bodenoberflächen, sowie Verfahren zum Lenken einer Straßenfräsmaschine |
| US12043601B2 (en) * | 2018-08-22 | 2024-07-23 | The Regents Of The University Of Colorado | N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same |
| AR117169A1 (es) | 2018-11-28 | 2021-07-14 | Bayer Ag | (tio)amidas de piridazina como compuestos fungicidas |
| JP2023529294A (ja) * | 2020-05-19 | 2023-07-10 | バイエル、アクチエンゲゼルシャフト、（ディビジョン、クロップサイエンス） | 殺真菌性化合物としてのアザ二環式（チオ）アミド |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3485840A (en) * | 1964-11-12 | 1969-12-23 | Hoffmann La Roche | 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes |
| US4515948A (en) * | 1973-09-12 | 1985-05-07 | Hoffmann-La Roche Inc. | 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines |
| US4013644A (en) * | 1976-03-15 | 1977-03-22 | G. D. Searle & Co. | [8 α(E), 13aβ]-5,8,13,13a-tetrahydro-2,3,10,11-tetramethoxy-8-(2-phenylethenyl)-6H-dibenzo[a,g]quinolizines and intermediates thereto |
| US4444770A (en) * | 1980-05-29 | 1984-04-24 | Bayer Aktiengesellschaft | New imidazoazole-alkenoic acid amide compounds, intermediate products for their production, their production, and their medicinal use |
| US4594199A (en) * | 1983-09-19 | 1986-06-10 | E. R. Squibb & Sons, Inc. | Method for making phosphinic acid intermediates |
| PT99514B (pt) * | 1990-11-14 | 1999-04-30 | Chiron Corp | Processo de preparacao de compostos para o tratamento de infeccoes fungicas |
| KR100417508B1 (ko) * | 1994-11-24 | 2004-03-18 | 바실리어 파마슈티카 아게 | 신규한벤질피리미딘 |
| WO1996040640A1 (en) * | 1995-06-07 | 1996-12-19 | Pfizer Inc. | BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION |
| JP3309340B2 (ja) * | 1995-12-04 | 2002-07-29 | アルピダ・アーゲー | ジアミノピリミジン、それらを含む医薬組成物及びそれらの抗菌剤としての用途 |
-
1997
- 1997-04-19 TW TW086105103A patent/TW438796B/zh active
- 1997-04-24 US US08/842,459 patent/US5866583A/en not_active Expired - Lifetime
- 1997-05-07 KR KR1019980709204A patent/KR100295509B1/ko not_active Expired - Fee Related
- 1997-05-07 DK DK97923018T patent/DK0901488T3/da active
- 1997-05-07 ES ES97923018T patent/ES2184089T3/es not_active Expired - Lifetime
- 1997-05-07 DE DE69716901T patent/DE69716901T2/de not_active Expired - Lifetime
- 1997-05-07 IL IL12670297A patent/IL126702A0/xx unknown
- 1997-05-07 EP EP97923018A patent/EP0901488B1/en not_active Expired - Lifetime
- 1997-05-07 BR BR9709251A patent/BR9709251A/pt not_active IP Right Cessation
- 1997-05-07 AT AT97923018T patent/ATE227282T1/de not_active IP Right Cessation
- 1997-05-07 PT PT97923018T patent/PT901488E/pt unknown
- 1997-05-07 CZ CZ983646A patent/CZ364698A3/cs unknown
- 1997-05-07 TR TR1998/02331T patent/TR199802331T2/xx unknown
- 1997-05-07 PE PE1997000356A patent/PE78898A1/es not_active Application Discontinuation
- 1997-05-07 CN CN97194633A patent/CN1098260C/zh not_active Expired - Fee Related
- 1997-05-07 WO PCT/EP1997/002355 patent/WO1997043277A1/en not_active Ceased
- 1997-05-07 JP JP09540486A patent/JP3098259B2/ja not_active Expired - Fee Related
- 1997-05-07 PL PL97330277A patent/PL330277A1/xx unknown
- 1997-05-07 AU AU28942/97A patent/AU726416B2/en not_active Ceased
- 1997-05-07 NZ NZ332481A patent/NZ332481A/xx unknown
- 1997-05-07 CA CA002254117A patent/CA2254117C/en not_active Expired - Fee Related
- 1997-05-08 ZA ZA9703984A patent/ZA973984B/xx unknown
- 1997-05-12 AR ARP970101966A patent/AR007088A1/es unknown
- 1997-05-14 CO CO97025823A patent/CO4840509A1/es unknown
- 1997-05-15 MA MA24620A patent/MA24182A1/fr unknown
- 1997-05-15 HR HR96107739.3A patent/HRP970260A2/xx not_active Application Discontinuation
-
1998
- 1998-11-13 YU YU51498A patent/YU51498A/sr unknown
- 1998-11-16 NO NO985335A patent/NO985335L/no not_active Application Discontinuation
-
2004
- 2004-02-20 CY CY0400011A patent/CY2425B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4840509A1 (es) | 2,4 diaminopirimidinas sustituidas, medicamento que contiene dichos compuestos para el control o la prevencion de enfermedades infecciosas y procedimiento para la preparacion de dichos compuestos" | |
| ECSP045229A (es) | Piridinonas sustituidas como moduladores de la p38 map quinasa | |
| BR0208678A (pt) | Composto, composição farmacêutica, uso de um composto | |
| FI960399A0 (fi) | Perhydroisoindolijohdannaisia P-aineen antagonisteina | |
| CO4970713A1 (es) | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen | |
| BR0012697A (pt) | Inibidores da diferenciação de th2 | |
| ES2183180T3 (es) | Nuevos derivados de guanidina, procedimientos para su preparacion y su uso como medicamento. | |
| FR2712591B1 (fr) | Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique. | |
| BR0309558A (pt) | Derivados de quinazolina e medicamentos | |
| ES2122637T3 (es) | Derivados de tiazolidina, su preparacion y los medicamentos que les contienen. | |
| DE69231445D1 (de) | Triazole enthaltende antifungizide mittel | |
| MX9405290A (es) | Derivados de piperazina y sales de los mismos, proceso para su preparaciony medicamentos que los contienen. | |
| DK0752854T3 (da) | Pyrimidin- eller triazincarboxylsyrederivater til anvendelse som lægemiddel | |
| HRP20050213A2 (en) | 2,4-substituted indoles and their use as 5-ht6 modulators | |
| ES551274A0 (es) | Un procedimiento para la sintesis de derivados de imidazol. | |
| AR027578A1 (es) | Derivados de indano | |
| ES2154453T3 (es) | Compuestos pertenecientes a la familia de los amidiniums, composiciones farmaceuticas que les contienen y sus aplicaciones. | |
| AR035003A1 (es) | Derivados de propanolamina relacionados con acidos biliares, procedimiento para su preparacion, medicamentos conteniendo estos compuestos y su empleo para la preparacion de medicamentos | |
| UA41350C2 (uk) | Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі | |
| CO4700299A1 (es) | Derivados de piperazina, medicamentos que contienen estos compuestos, su empleo y procedimiento para su preparacion | |
| HUT70761A (en) | Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof | |
| NO20000423D0 (no) | Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene | |
| DK477783A (da) | 1,3,4,6,7-11b-hexahydro-7-aryl-2h-pyrazino(2,1-a)-isoquinoliner, fremgangsmaade til fremstilling heraf og deres anvendelse som mellemprodukter og laegemidler | |
| ES2094048T3 (es) | N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina. | |
| TR200400907T4 (tr) | Beta D 5-Tiyoksiloz türevleri, bunları hazırlama yöntemi ve bunların terapötik kullanımları |